| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |